With $9.7 billion acquisition, Novartis bets that heart drugs are coming back
The day I ‘declared myself’ — and was in surgery just hours later
The FDA must pull Makena off the market
Name the much-criticized federal program that has saved the U.S. $2.3 trillion. Hint: it starts with Affordable
Overprescribed: High cost isn’t America’s only drug problem
